Physician profile
Juli A Ackerman
NPI 1619292927
$3,034.04
in general payments reported to CMS, 2019-2025
34 companies · $743 in 2025
The $743 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $217 · 2021: $296 · 2022: $386 · 2023: $667 · 2024: $504 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $554.01 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $418.59 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $415.93 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $261.91 | 2021-2024 | Vraylar |
| Novo Nordisk INC | $189.25 | 2019-2024 | Rybelsus, Ozempic |
| Amgen INC. | $139.90 | 2019-2025 | Evenity, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.41 | 2019-2024 | Ofev |
| Astellas Pharma US INC | $114.44 | 2025 | Veozah |
| Abbott Laboratories | $74.71 | 2021-2023 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $71.66 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $65.19 | 2023-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $49.52 | 2025 | Caplyta |
| Pfizer INC. | $42.49 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $42.09 | 2021-2022 | |
| Organon LLC | $38.03 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $37.13 | 2022 | |
| Inspire Medical Systems, INC. | $36.66 | 2024 | Inspire |
| Allergan, INC. | $33.61 | 2019-2020 | |
| Exact Sciences Corporation | $33.19 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $32.00 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $28.29 | 2023-2024 | Eliquis |
| Sanofi-Aventis U.S. LLC | $28.17 | 2019 | |
| Boston Scientific Corporation | $27.13 | 2024 | Watchman Flx |
| Insmed, INC. | $25.57 | 2025 | Brinsupri, Arikayce |
| Ibsa Pharma INC. | $23.70 | 2025 | Flector, Tirosint, Licart |
| Corcept Therapeutics | $19.28 | 2024 | Korlym |
| Alkermes, INC. | $17.46 | 2022 | |
| Medtronic Vascular, INC. | $16.94 | 2020 | |
| Neurocrine Biosciences, INC. | $15.84 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $14.82 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.64 | 2019 | |
| Eisai INC. | $12.27 | 2020 | |
| Gilead Sciences, INC. | $12.16 | 2019 | |
| Grifols USA, LLC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juli Ackerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.